<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<!--<?xml-stylesheet type="text/xsl" href="article.xsl"?>-->
<article article-type="research-article" dtd-version="1.0" xml:lang="en"
    xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <front>
        <journal-meta>
            <journal-id journal-id-type="issn">0973-7510</journal-id>
            <journal-title-group>
                <journal-title>Journal of Pure and Applied Microbiology</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2581-690X</issn>
            <publisher>
                <publisher-name>DR. M.N. Khan</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.22207/JPAM.10.4.03</article-id>
            <title-group>
                <article-title>Cephalosporin C Acylase from Microbes for
One-step Enzymatic Transformation of Cephalosporin C to
7-Aminocephalosporanic Acid</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Hardianto</surname>
                        <given-names>Dudi</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
					
					 </contrib>
				
				<contrib contrib-type="author">
                    <name>
                        <surname>Royani</surname>
                        <given-names>Juwartina Ida</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
				<contrib contrib-type="author">
                    <name>
                        <surname>Safarrida</surname>
                        <given-names>Anna</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
		
            </contrib-group>
			
			
            <aff id="aff-1">Agency for the Assessment and Application of Technology,
LAPTIAB Building, Puspiptek Area, 15314, Indonesia.</aff>
	 
			
			
            <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2016-12-30">
                <day>30</day>
                <month>12</month>
                <year>2016</year>
            </pub-date>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>2495</fpage>
            <lpage>2499</lpage>
            <permissions>
                <copyright-statement>Copyright &#x00A9; 2016 The Author(s)</copyright-statement>
                <copyright-year>2016</copyright-year>
                <license license-type="open-access"
                    xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.<uri 
					xlink:href="https://creativecommons.org/licenses/by/4.0/"
                            >https://creativecommons.org/licenses/by/4.0/</uri></license-p>
                </license>
            </permissions>
            <self-uri xlink:href="https://www.microbiologyjournal.org/cephalosporin-c-acylase-from-microbes-for-one-step-enzymatic-transformation-of-cephalosporin-c-to-7-aminocephalosporanic-acid/"/>
            <abstract>
                <p>Cephalosporins are the β-lactam antibiotics for the treatment of infection
diseases caused by gram-positive and gram-negative bacteria. Fungus Cephalosporium
acremonium produces cephalosporin C (CPC) that is not potent for clinical use. Its
molecule can be transformed to 7-amino cephalosporanic acid (7-ACA) as the intermediate
compound for making semi-synthetic cephalosporin derivatives. The first method for
production of 7-aminocephalosporanic acid involves the chemical reaction using toxic
reagents and laborious procedures. The second method uses two-step and one-step
enzymatic transformation. In two-step method, the first step involves the conversion of
Ceph-C to Glutaryl-7-amino cephalosporanic acid (GL-7-ACA) by D-amino acid oxidase
(DAAO) and the second step, GL-7-ACA acylase (GA) hydrolyzes GL-7- ACA to produce 7-
ACA. The two-step enzymatic transformation was used widely because of its safety and
environmental friendship. The one-step enzymatic transformation is developed because
of process simplification and cost reduction. This method uses cephalosporin C acylase
for transformation CPC to 7-ACA. Same microbes can produce cephalosporin C acylase
such as Achromobacter xylosoxidans, Aeromonas sp., Arthrobacter viscosus, Bacillus
laterosporus, Flavobacterium sp., Paecilomyces sp., and Pseudomonas sp. The natural
of cephalosporin C acylase catalyzed the CPC to 7-ACA directly in a very low efficiency
and the protein engineering of cephalosporin C acylase was used to increase activity.
		</p>
		</abstract>
		<kwd-group>
        <title>Keywords</title>
        <kwd>Cephalosporin C</kwd>
        <kwd>7-aminocephalosporanic acid</kwd>
         <kwd>D-amino acid oxidase</kwd>
			<kwd>GL-7-ACA acylase</kwd>
			<kwd>cephalosporin C acylase</kwd>
			<kwd>Cephalosporium acremonium</kwd>
         </kwd-group>
        </article-meta>
    </front>
    </article>
